Fingerprint
Dive into the research topics of 'Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically